[HTML][HTML] Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease

S Pugazhenthi, L Qin, PH Reddy - … acta (BBA)-molecular basis of disease, 2017 - Elsevier
Cognitive decline in chronic diabetic patients is a less investigated topic. Diabetes and
obesity are among the modifiable risk factors for Alzheimer's disease (AD), the most …

[HTML][HTML] The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes

JD Erusalimsky - Redox Biology, 2021 - Elsevier
The soluble receptor for advanced glycation end-products (sRAGE) has been classically
considered a sink for pro-inflammatory RAGE ligands and as such has been associated with …

The diabetic cardiomyopathy: the contributing pathophysiological mechanisms

T Salvatore, PC Pafundi, R Galiero, G Albanese… - Frontiers in …, 2021 - frontiersin.org
Individuals with diabetes mellitus (DM) disclose a higher incidence and a poorer prognosis
of heart failure (HF) than non-diabetic people, even in the absence of other HF risk factors …

Advanced glycation end products (AGEs) and chronic kidney disease: does the modern diet AGE the kidney?

AK Fotheringham, LA Gallo, DJ Borg, JM Forbes - Nutrients, 2022 - mdpi.com
Since the 1980s, chronic kidney disease (CKD) affecting all ages has increased by almost
25%. This increase may be partially attributable to lifestyle changes and increased global …

[HTML][HTML] Diabetes is a risk factor for knee osteoarthritis progression

F Eymard, C Parsons, MH Edwards, F Petit-Dop… - Osteoarthritis and …, 2015 - Elsevier
Purpose Recent studies have suggested that metabolic factors (obesity, diabetes,
hypertension and dyslipidemia) and their clustering in metabolic syndrome (MetS) might be …

Biomarkers of cellular senescence and risk of death in humans

JL St. Sauver, SA Weston, EJ Atkinson… - Aging …, 2023 - Wiley Online Library
A robust and heterogenous secretory phenotype is a core feature of most senescent cells. In
addition to mediators of age‐related pathology, components of the senescence associated …

Unlocking the biology of RAGE in diabetic microvascular complications

MB Manigrasso, J Juranek, R Ramasamy… - Trends in Endocrinology …, 2014 - cell.com
The discovery of the receptor for advanced glycation end-products (RAGE) set the stage for
the elucidation of important mechanisms underpinning diabetic complications. RAGE …

[HTML][HTML] Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions

KJ Welsh, MS Kirkman, DB Sacks - Diabetes care, 2016 - ncbi.nlm.nih.gov
Blood oligosaccharides are attached to many proteins after translation, forming
glycoproteins. Glycosylation refers to an enzyme-mediated modification that alters protein …

Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism

K Gutowska, K Czajkowski, A Kuryłowicz - International journal of …, 2023 - mdpi.com
Advanced glycation end products (AGEs) are mediators in the process of cellular
dysfunction in response to hyperglycemia. Numerous data indicate that the accumulation of …

Determinants of bone material strength and cortical porosity in patients with type 2 diabetes mellitus

P Samakkarnthai, JG Sfeir, EJ Atkinson… - The Journal of …, 2020 - academic.oup.com
Context Reduced bone material strength index (BMSi) and increased cortical porosity (CtPo)
have emerged as potentially contributing to fracture risk in type 2 diabetes mellitus (T2DM) …